Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats

被引:37
作者
Saeki, M
Sakai, M
Saito, R
Kubota, H
Ariumi, H
Takano, Y
Yamatodani, A
Kamiya, H
机构
[1] Hisamitsu Pharmaceut Co Inc, Fundamental Res Labs, Tsukuba, Ibaraki 3050856, Japan
[2] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmacol, Fukuoka 8140180, Japan
[3] Osaka Univ, Fac Med, Sch Allied Hlth Sci, Dept Med Phys, Suita, Osaka 5650871, Japan
关键词
cisplatin-induced pica; tachykinin NK1-receptor antagonist; delayed emesis;
D O I
10.1254/jjp.86.359
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of a novel tachykinin NK1-receptor antagonist HSP-117 {(2S,3S)-3-[(5-isopropyI2,3-dihydrobenzofuran-7-yl)methyl]amino-2-phenylpiperidine dihydrochloride on cisplatin-induced pica, i.e., the eating of nonnutritive substances such as kaolin were examined in rats. HSP-117 inhibited kaolin intake in a dose-dependent manner for 2 days. The 5-HT3-receptor antagonist ondansetron inhibited only on the first day, but not on the second day. These results indicate that the cisplatin-induced kaolin intake on the first day is related to both 5-HT3- and NK1 receptors, while only the NK1 receptor is involved on the second day. Thus, cisplatin-induced continuous pica in rats represents a useful model of not only acute but also delayed emesis.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 15 条
[1]   The role of tachykinin NK-1 receptors in the area postrema of ferrets in emesis [J].
Ariumi, H ;
Saito, R ;
Nago, S ;
Hyakusoku, M ;
Takano, Y ;
Kamiya, H .
NEUROSCIENCE LETTERS, 2000, 286 (02) :123-126
[2]   ANTIEMETIC PROFILE OF A NONPEPTIDE NEUROKININ-NK(1) RECEPTOR ANTAGONIST, CP-99,994, IN FERRETS [J].
BOUNTRA, C ;
BUNCE, K ;
DALE, T ;
GARDNER, C ;
JORDAN, C ;
TWISSELL, D ;
WARD, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (01) :R3-R4
[3]   Towards understanding the aetiology and pathophysiology of the emetic reflex: Novel approaches to antiemetic drugs [J].
Bountra, C ;
Gale, JD ;
Gardner, CJ ;
Jordan, CC ;
Kilpatrick, GJ ;
Twissell, DJ ;
Ward, P .
ONCOLOGY, 1996, 53 :102-109
[4]   The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040 [J].
Gardner, CJ ;
Twissell, DJ ;
Dale, TJ ;
Gale, JD ;
Jordan, CC ;
Kilpatrick, GJ ;
Bountra, C ;
Ward, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (08) :3158-3163
[5]   GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity [J].
Gardner, CJ ;
Armour, DR ;
Beattie, DT ;
Gale, JD ;
Hawcock, AB ;
Kilpatrick, GJ ;
Twissell, DJ ;
Ward, P .
REGULATORY PEPTIDES, 1996, 65 (01) :45-53
[6]   Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets [J].
Gonsalves, S ;
Watson, J ;
Ashton, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) :181-185
[7]   The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret [J].
Rudd, JA ;
Jordan, CC ;
Naylor, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (05) :931-936
[8]   An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret [J].
Rudd, JA ;
Naylor, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :209-214
[9]   In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists [J].
Rupniak, NMJ ;
Tattersall, FD ;
Williams, AR ;
Rycroft, W ;
Carlson, EJ ;
Cascieri, MA ;
Sadowski, S ;
Ber, E ;
Hale, JJ ;
Mills, SG ;
MacCoss, M ;
Seward, E ;
Huscroft, I ;
Owen, S ;
Swain, CJ ;
Hill, RG ;
Hargreaves, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (2-3) :201-209
[10]   Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets [J].
Saito, R ;
Suehiro, Y ;
Ariumi, H ;
Migita, K ;
Hori, N ;
Hashiguchi, T ;
Sakai, M ;
Saeki, M ;
Takano, Y ;
Kamiya, HO .
NEUROSCIENCE LETTERS, 1998, 254 (03) :169-172